Pinnacle Financial Partners (Georgia)
KRYS icon

Pinnacle Financial Partners (Georgia)’s Krystal Biotech KRYS Stock Holding History

Pinnacle Financial Partners (Georgia)’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.52M Buy
20,243
+63
+0.3% +$18.8K 0.05% 255
2026
Q1 		$5.21M Buy
20,180
+3,197
+19% +$851K 0.04% 293
2025
Q4 		$4.19M Buy
+16,983
New +$3.57M 0.03% 320

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Avoro Capital Advisors
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Soleus Capital Management
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Pinnacle Financial Partners (Georgia)'s KRYS Position: Q2 2026 in Review

Pinnacle Financial Partners (Georgia) increased its Krystal Biotech (KRYS) stake by 0.31% in Q2 2026, buying an estimated $18.8K and bringing the position to 20,243 shares worth $7.52M. The position accounts for 0.05% of the portfolio, ranked #255.

Pinnacle Financial Partners (Georgia) first reported a position in KRYS in Q4 2025 and has held it in 3 quarters since. 423 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

  • Pinnacle Financial Partners (Georgia) held 20,243 shares of Krystal Biotech worth $7.52M as of Q2 2026.
  • Pinnacle Financial Partners (Georgia) bought 63 Krystal Biotech shares in Q2 2026, an estimated $18.8K.
  • Krystal Biotech made up 0.05% of Pinnacle Financial Partners (Georgia)'s portfolio in Q2 2026, its #255 holding.
  • Pinnacle Financial Partners (Georgia) first reported a position in Krystal Biotech in Q4 2025 and has held it in 3 quarters since.
  • 423 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on Pinnacle Financial Partners (Georgia)'s 13F filing for Q2 2026, filed 14 Aug 2026.